2024AURGC

Tuesday, April 30, 2024

Annualreport
About

Thank you to each and every person that participated in this PEEK study.

THIS IS A PEEK STUDY IN PARTNERSHIP WITH

. .

This study was generously sponsored by a consortium including Illumina, Alexion, Novartis, Pfizer and Roche.

Headquarters
Pl. du Petit-Saconnex 1
1209 Genève
Switzerland

E: administration@cc-dr.org

UK office
Ground Floor, Wessex House, Pixash Lane
Keynsham, Bristol, BS31 1TP
United Kingdom

Australian office
Level 4, Plaza Offices East,
35 Terminal Avenue, Canberra Airport
ACT 2609

+61 (0)2 8294 6760

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

SAVE & ACCEPT